-transparent.png){kind=logo}
We describe 2 adult patients with acute lymphoblastic leukaemia (ALL) who died from pulmonary embolism following L-asparaginase treatment. Since this drug is known to cause a decrease in antithrombin III, the most important protein physiologically involved in the neutralization of thrombin, we studied the behaviour of this inhibitor in 14 ALL patients treated with a protocol including a 14-day course of L-asparaginase. A significant but transient fall of biological and immunological antithrombin III and a concomitant reduction of fibrinogen were documented.
Related Publications
T Barbui, and
F Rodeghiero, and
S Meli, and
E Dini
January 1994,
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis,
T Barbui, and
F Rodeghiero, and
S Meli, and
E Dini
March 1980,
Lancet (London, England),
T Barbui, and
F Rodeghiero, and
S Meli, and
E Dini
March 1980,
Lancet (London, England),
T Barbui, and
F Rodeghiero, and
S Meli, and
E Dini
January 1980,
Medical and pediatric oncology,
T Barbui, and
F Rodeghiero, and
S Meli, and
E Dini
November 1981,
Archives francaises de pediatrie,
T Barbui, and
F Rodeghiero, and
S Meli, and
E Dini
January 1984,
Acta haematologica,
T Barbui, and
F Rodeghiero, and
S Meli, and
E Dini
November 1985,
Fortschritte der Medizin,
T Barbui, and
F Rodeghiero, and
S Meli, and
E Dini
January 1988,
Medical and pediatric oncology,
T Barbui, and
F Rodeghiero, and
S Meli, and
E Dini
May 1980,
Lancet (London, England),
T Barbui, and
F Rodeghiero, and
S Meli, and
E Dini
December 2002,
Pediatric hematology and oncology,
